BHCM
MRVI icon

Brevan Howard Capital Management’s Maravai LifeSciences MRVI Stock Holding History

Brevan Howard Capital Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,090
Closed -$28.6K – 2399
2026
Q1 		$28.6K Buy
+10,090
New +$34.2K ﹤0.01% 2108
2025
Q4 		– Sell
-24,093
Closed -$69.1K – 2116
2025
Q3 		$69.1K Buy
+24,093
New +$61.5K ﹤0.01% 1887
2024
Q1 		– Sell
-22,414
Closed -$147K – 1225
2023
Q4 		$147K Buy
+22,414
New +$145K ﹤0.01% 917

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Brevan Howard Capital Management's MRVI Position: Q2 2026 in Review

Brevan Howard Capital Management sold out of Maravai LifeSciences (MRVI) in Q2 2026, closing a stake of 10,090 shares — an estimated $28.6K sold.

Brevan Howard Capital Management first reported a position in MRVI in Q4 2023 and held it in 3 quarters. The position peaked at $147K in Q4 2023. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • Brevan Howard Capital Management reported no remaining Maravai LifeSciences position as of Q2 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 10,090 Maravai LifeSciences shares in Q2 2026, an estimated $28.6K.
  • Brevan Howard Capital Management first reported a position in Maravai LifeSciences in Q4 2023 and held it in 3 quarters.
  • Brevan Howard Capital Management's Maravai LifeSciences position peaked at $147K in Q4 2023.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.